TrialNeuropsychopharmacology reports2020

Long-term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention-deficit/hyperactivity disorder.

Hironobu Ichikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.